Cost-effectiveness of Intensive Blood Pressure Management
Richman IB, Fairley M, Jørgensen ME, Schuler A, Owens DK, Goldhaber-Fiebert JD. Cost-effectiveness of Intensive Blood Pressure Management. JAMA Cardiology 2016, 1: 872-879. PMID: 27627731, PMCID: PMC5892423, DOI: 10.1001/jamacardio.2016.3517.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntihypertensive AgentsBlood PressureCardiovascular DiseasesCost-Benefit AnalysisHealth Care CostsHeart FailureHumansHypertensionQuality-Adjusted Life YearsConceptsIntensive blood pressure managementSystolic Blood Pressure Intervention TrialBlood pressure managementAdverse event ratesStandard managementPressure managementAdverse eventsPopulation-based observational dataSystolic blood pressure goalEvent ratesHigher adverse event ratesBlood pressure goalsSerious adverse eventsHigh-risk patientsHigh-risk adultsSystolic blood pressureNational Inpatient SampleTreatment of hypertensionCause-specific mortalityLifetime costsMarkov cohort modelCost-effectiveness analysisCardiovascular morbidityBlood pressureHeart failure